OutreAch MediCal Care for HousEbound Patients With Post-COVID-19 Syndrome or ME/CFS of Any Cause (ACCESS)

Recruiting N/A Interventional Study
ME/CFS
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 69
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
100 (estimated)
Sponsor
Hannover Medical School · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The significance of the Post-COVID Syndrome (PCS) has been widely acknowledged. Various efforts are made to find out about the pathomechanisms behind PCS and to establish therapies. One sub-group of PCS-patients, however, is generally excluded from any studies, and that are those who are unable to visit outpatient clinics or hospitals for diagnostic work up or participation in clinical trials, as …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * ME/CFS according to the Canadian Consensus Criteria * Bell Score ≤ 30 * Duration of the postexertional malaise (PEM) \> 14 hours * Age \> 18 years and \< 70 Exclusion Criteria: \- Pre-existing conditions or comorbidities that have (or could have) led to a restriction of mobi…
Contacts

Meike Dirks, MD

+495115323145

access-patienten@mh-hannover.de

CONTACT

Karin Weissenborn, Professor

dirks.meike@mh-hannover.de

CONTACT